CDKN2A and neoplasm: More recently, CDK6 has also been shown to have a transcriptional role in tumour angiogenesis, being a part of a transcription complex that induces the expression of the tumour suppressor p16INK4a and the pro-angiogenic factor VEGF-A [109].